| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Imiquimod |
|---|
| Description | A TLR7 agonist (EC50 = 2.12 μM); increases TNF-α and IL-12 p40 production in IFN-γ-treated murine peritoneal macrophages in a concentration- and MyD88-dependent manner; topical application of a 5% cream increases TNF and IFN levels at the application site in hairless mice; dose-dependently increases serum levels of IFN-α in mice when administered by gavage; reduces tumor growth in an MC-26 model of murine colon cancer at 30 mg/kg every three days; reduces vaginal viral titer and lesion formation in a guinea pig model of genital HSV-2 infection at 5 mg/kg, intravaginally, twice daily |
|---|
| Size | 250 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | R-837|S-26308|TMX 101 |
|---|
| Gene, Accession, CAS # | CAS: 99011-02-6 |
|---|
| Catalog # | 14956-250 |
|---|
| Price | |
|---|
| Order / More Info | Imiquimod from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|